Effects of denosumab on bone turnover markers in men receiving androgen deprivation therapy for prostate cancer: results of a randomized, double-blind, placebo-controlled trial

  • M Smith (Contributor)
  • F Saad (Contributor)
  • B Egerdie (Contributor)
  • Tammela, T. (Contributor)
  • C Ke (Contributor)
  • B Leder (Contributor)
  • C Goessl (Contributor)

    Activity: Talk or presentationConference presentation


    Contributors: Smith M, Saad F, Egerdie B, Tammela T, Ke C , Leder B, Goessl C / J Bone Miner Res. 24 (Suppl 1).
    Period14 Sept 2009
    Event title31st Annual Meeting of The American Society for Bone and Mineral Research, ASBMR
    Event typeOther
    Degree of RecognitionInternational